Published: 01 January 1970, 12:00pm
Report ID
#
NHI
Date of birth
01 Jan 1970
BRRISK is a validated risk model (using BOADICEA developed by University of Cambridge, Department of Public and Primary Care) to stratify risk of breast cancer.
Stratification into population, moderate or high risk helps you to triage patients into the right surveillance pathway and determining who to refer to specialists either in Private or Public.
This is an objective assessment. Patients enter their information into a web-based application, which is intuitive and friendly to use, so they can present you with a report for your consult.
Further information about BRRISK can be found here brrisk.co/about-brrisk (URL to be finalised)
Your patients lifetime risk from age 20 of having breast cancer is 0.00%. According to the eviQ guidelines they would be in the Population risk category.
Your patients risk between ages 40 and 50 of having breast cancer is 0.00%. According to the eviQ guidelines they would be in the Population risk category.
International guidelines providing the risk management strategies.
Near population risk | Moderate risk | High risk | |
---|---|---|---|
Lifetime risk from age 20 | Less than 17% | 17% or greater but less than 30% | 30% or greater |
Risk between ages 40 and 50 | Less than 3% | 3% or greater to 8% | Greater than 8% |
The following information is provided as a guide only and is based on eviQ guidelines. Clinical decisions are always between the women and her GP / Specialist.
The impact of lifestyle on cancer risk should be discussed e.g.exercise regularly, maintain healthy weight, have a healthy diet, limit alcohol intake, do not smoke, avoid excessive sun exposure and minimise exogenous estrogen and progesterone exposure
Women with this level of risk are considered to be at population risk of breast cancer.
Women with this level of risk are considered to have a “moderately increased” risk of breast cancer when compared to the general population.
Surgical |
---|
Risk-reducing mastectomy is not recommended. |
Surveillance | |
---|---|
Age | Strategy and Frequency |
All ages | Breast awareness with prompt reporting to general practitioner of persistent or unusual changes |
Between 40 to 50 years | Recommended yearly mammograms |
Between 50 to 59 years | Offer mammograms 2 yearly. Consider yearly in women with additional risk factors |
From 60 years | Recommended mammograms every 2 years |
Risk reducing medication |
---|
|
Women with this level of risk are considered to be significantly higher when compared to the general population.
Surgical |
---|
Discuss bilateral risk reducing mastectomy |
Surveillance | |
---|---|
Age | Strategy and Frequency |
< 40 years |
|
> 40 years | Recommend annual breast MRI until at least age 50 (and longer if dense breasts) + annual mammography (digital, consider tomosynthesis where possible) |
Risk reducing medication |
---|
Discuss risk reducing medication |